Financial Reports and Presentations - Acacia Pharma Group Plc

Investors > Financial Reports and Presentations

US Approval of BYFAVO conference call presentation

Acacia Pharma Group plc Annual Report and Financial Statements for the year ended 31 December 2019

Results for the Year Ended 31 December 2019

BARHEMSYS® approved by US FDA - 27 February 2020

Cosmo Agreement - Conference Call Presentation 10 Jan 2020

Interim Results 2019 Presentation

Interim Results for the Six Months ended 30 June 2019

Notice of 2019 AGM

2019 AGM Form of Proxy

Annual Report and Consolidated Financial Statements for the year ended 31 December 2018

Results for the year ended 31 December 2018

Unaudited Results for the nine months to 30 September 2018

Interim results for the First Half Year 2018

Annual Report and Consolidated Financial Statements for the year ended 31 December 2017